Prophylaxis of influenza infection
Conditions
Interventions
investigational material(s)
Generic name etc : VN-0104(Seasonal influenza quadrivalent vaccine)
INN of investigational material :
Therapeutic category code : 631 Vaccines
Dosage and Administration fo
Sponsors
DAIICHISANKYO Co.,Ltd.
KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Japanese healthy adult volunteers
Exclusion criteria
Exclusion criteria: 1) Subjects with history of seasonal influenza in the past 6 months 2) Subjects with history of seasonal influenza vaccination in the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety endpoints: adverse events, body temperature Immunology endpoints: HI antibody titer, SRH antibody titer, Neutralizing antibody titer | — |
Outcome results
None listed